Single‐Cell Sequencing of Diffuse Midline Glioma Reveals That CTHRC1 Promotes Tumor Malignant Progression via the Wnt/β‐Catenin/ MMP2 Signaling Pathway
IUBMB Life · 2026-10 · 78 (10)
DOI: 10.1002/iub.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 28.10.2026. Verfasst von Yong Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Glioma, Matrix Metalloproteinase 2, Wnt Signaling Pathway, Extracellular Matrix Proteins. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Yuntao Lu, Linyong Shi.
Abstract (Originalsprache)
Despite the continuous advancement of neurosurgical techniques and the accelerated pace of drug development, the prognosis of diffuse midline glioma (DMG) remains unsatisfactory. Reports on the cellular atlas and biological characteristics of DMG remain relatively scarce. With the rapid development of biotechnology, especially single‐cell transcriptome technology, people's understanding of the tumor microenvironment (TME) of DMG can be effectively enhanced. Here, we performed an integrated analysis of single‐cell transcriptome profiles from 3 DMG samples collected from our center to investigate the characteristics of intratumoral heterogeneity and the TME. As a core component of DMG tumor cells, oligodendrocyte progenitor cells (OPCs) are predominantly localized in the cellular tumor (CT) region, whereas OPCs in the leading edge (LE) and microvascular proliferation (MVP) regions contribute to immune suppression. The pseudotime trajectory of monocyte‐derived macrophages (MDMs) demonstrates that they infiltrate the tumor tissues via the microvascular proliferation (MVP) and leading edge (LE) regions, and then migrate toward the tumor core (CT) or pseudo‐palisading cells around necrosis (PAN) regions, which is correlated with tumor immune suppression. In addition, CTHRC1 can promote the malignant progression of DMG via the Wnt/β‐catenin/MMP2 signaling pathway. Together, our work provides an in‐depth understanding of the microenvironment of DMG, thereby laying a framework for uncovering targeted therapeutic strategies for DMG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Nanfang Glioma Center, Guangzhou, China.
- Institute of Brain Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Förderung
- Yuntao Lu
- Linyong Shi
Zitieren
APA
Gao, Y., Yu, Z., Xie, Y., Chen, L., Shi, L., Zhu, R., & Lu, Y. (2026). Single‐Cell Sequencing of Diffuse Midline Glioma Reveals That CTHRC1 Promotes Tumor Malignant Progression via the Wnt/β‐Catenin/ MMP2 Signaling Pathway. IUBMB Life, 78(10). https://doi.org/10.1002/iub.70132
Vancouver
Gao Y, Yu Z, Xie Y, Chen L, Shi L, Zhu R, et al. Single‐Cell Sequencing of Diffuse Midline Glioma Reveals That CTHRC1 Promotes Tumor Malignant Progression via the Wnt/β‐Catenin/ MMP2 Signaling Pathway. IUBMB Life. 2026;78(10). doi:10.1002/iub.70132
BibTeX
@article{Gao2026,
author = {Gao, Yong and Yu, Ziyuan and Xie, Yinan and Chen, Lei and Shi, Linyong and Zhu, Rongzhang and Lu, Yuntao},
title = {Single‐Cell Sequencing of Diffuse Midline Glioma Reveals That CTHRC1 Promotes Tumor Malignant Progression via the Wnt/β‐Catenin/ MMP2 Signaling Pathway},
journal = {IUBMB Life},
year = {2026},
volume = {78},
number = {10},
doi = {10.1002/iub.70132}
}
EUVIMED